A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma.
Korde N, Carlsten M, Lee MJ, Minter A, Tan E, Kwok M, Manasanch E, Bhutani M, Tageja N, Roschewski M, Zingone A, Costello R, Mulquin M, Zuchlinski D, Maric I, Calvo KR, Braylan R, Tembhare P, Yuan C, Stetler-Stevenson M, Trepel J, Childs R, Landgren O.
Korde N, et al. Among authors: bhutani m.
Haematologica. 2014 Jun;99(6):e81-3. doi: 10.3324/haematol.2013.103085. Epub 2014 Mar 21.
Haematologica. 2014.
PMID: 24658821
Free PMC article.
Clinical Trial.
No abstract available.